Dr. Rashmi has completed her Ph.D. from Indian Institute of Technology Bombay, Mumbai, in Protein Chemistry and is Founder and Head of Operations at QAWaCh Bio. Under her leadership, QAWaCh Bio has secured a number of fundings from most prestigious government agencies like, BIRAC (Dept. of Biotechnology) and DST (Dept. of Science & Technology). She has a strong knowledge of market gap analysis and statutory and regulatory requirements related with investigational or novel medical devices in India. She has a good understanding of Quality by design (QbD) which has helped QAWaCh Bio in producing consistently quality product batch to batch. She is driven by the vision of making ultra-sensitive point-of-care, affordable diagnostic solutions accessible to masses, especially for people at the bottom of economy pyramid. Under her guidance, QAWaCh Bio team has developed first-of-its-kind quantitative lateral flow immuno-assay platform that uses a combination of a test card and smartphone application giving results within 10-15 minutes. This platform is being clinically validated on Indian population, with CDSCO approvals for the study, in hand. She has a thorough knowledge of the life cycle of a novel in vitro diagnostic product, all the way from its R&D, regulatory approvals in India, clinical testing and performance evaluation study and securing manufacturing license.